tiprankstipranks
Advertisement
Advertisement

SEPN Stock Latest News

Septerna to present preclinical characterization of SEP-479
The FlySepterna to present preclinical characterization of SEP-479
5h ago
SEPN
Septerna price target raised to $53 from $47 at Raymond James
PremiumThe Fly
Septerna price target raised to $53 from $47 at Raymond James
6h ago
SEPN
3 Unknown Small-Cap Stocks with ‘Strong Buy’ Ratings and Up to 70% Upside in 2026
PremiumMarket News
3 Unknown Small-Cap Stocks with ‘Strong Buy’ Ratings and Up to 70% Upside in 2026
13d ago
ANGO
KRNT
Septerna Initiated with Buy Rating on Advancing GPCR Pipeline, Strong Early Data and Novo Nordisk Partnership Support
PremiumRatings
Septerna Initiated with Buy Rating on Advancing GPCR Pipeline, Strong Early Data and Novo Nordisk Partnership Support
27d ago
SEPN
Septerna reports Q1 EPS (19c), consensus (27c)
PremiumThe Fly
Septerna reports Q1 EPS (19c), consensus (27c)
28d ago
SEPN
Septerna initiated with a Buy at Stifel
PremiumThe FlySepterna initiated with a Buy at Stifel
1M ago
SEPN
3 Best Tech Stocks to Buy this Week 04/15/26, According to Top Analysts
Premium
Market News
3 Best Tech Stocks to Buy this Week 04/15/26, According to Top Analysts
2M ago
ALLT
CLBT
Septerna: Advancing GPCR Pipeline and Strategic Partnerships Support Buy Rating and $40 Price Target
Premium
Ratings
Septerna: Advancing GPCR Pipeline and Strategic Partnerships Support Buy Rating and $40 Price Target
2M ago
SEPN
Septerna Begins Phase 1 Trial of Oral SEP-479
PremiumCompany Announcements
Septerna Begins Phase 1 Trial of Oral SEP-479
2M ago
8K
SEPN
Septerna doses first patients in SEP-479 trial
PremiumThe Fly
Septerna doses first patients in SEP-479 trial
2M ago
SEPN
Septerna price target raised to $38 from $34 at JPMorgan
PremiumThe Fly
Septerna price target raised to $38 from $34 at JPMorgan
3M ago
SEPN
Septerna, Inc. (SEPN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Septerna, Inc. (SEPN) Q4 Earnings Cheat Sheet
3M ago
SEPN
Septerna price target raised to $35 from $34 at Truist
PremiumThe FlySepterna price target raised to $35 from $34 at Truist
3M ago
SEPN
Septerna files automatic mixed securities shelf
Premium
The Fly
Septerna files automatic mixed securities shelf
3M ago
SEPN
Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating
Premium
Ratings
Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating
3M ago
SEPN
Septerna reports Q4 EPS (24c), consensus (22c)
PremiumThe Fly
Septerna reports Q4 EPS (24c), consensus (22c)
3M ago
SEPN
Septerna (SEPN): Early Proof-of-Concept for SEP-631 in Mast Cell–Driven Disease Supports Long-Term Growth Potential
PremiumRatings
Septerna (SEPN): Early Proof-of-Concept for SEP-631 in Mast Cell–Driven Disease Supports Long-Term Growth Potential
3M ago
SEPN
Septerna price target raised to $40 from $35 at H.C. Wainwright
PremiumThe Fly
Septerna price target raised to $40 from $35 at H.C. Wainwright
3M ago
SEPN
Septerna Advances SEP-631 After Positive Phase 1 Results
PremiumCompany Announcements
Septerna Advances SEP-631 After Positive Phase 1 Results
3M ago
8K
SEPN
Septerna announces results from Phase 1 trial of SEP-631
PremiumThe FlySepterna announces results from Phase 1 trial of SEP-631
3M ago
SEPN
Septerna: Advancing GPCR Pipeline and De-Risked Valuation Support Upgraded Buy Rating and $35 Target
Premium
Ratings
Septerna: Advancing GPCR Pipeline and De-Risked Valuation Support Upgraded Buy Rating and $35 Target
5M ago
SEPN
Septerna price target raised to $35 from $30 at H.C. Wainwright
Premium
The Fly
Septerna price target raised to $35 from $30 at H.C. Wainwright
5M ago
SEPN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >